Introduction
============

Periodontal disease is a chronic inflammatory disease and the major cause of teeth loss in adults ([@b1-ijmm-43-06-2341]). The pathogenesis of periodontal disease is due to the microorganisms that adhere to and grow on the surfaces of teeth or periodontal tissues, triggering chronic inflammatory reactions and subsequently damaging the connection of periodontal soft tissues to facilitate the absorption of alveolar bone. This leads to destruction of the structures supporting the teeth and eventual tooth loss ([@b2-ijmm-43-06-2341],[@b3-ijmm-43-06-2341]). Currently, there are no effective treatment methods for periodontal disease. The periodontal ligament contains a group of pluripotent periodontal stem cells, which can express surface markers of mesenchymal stem cells with the characteristics of self-renewal and pluripotency ([@b4-ijmm-43-06-2341]).~.~ Human periodontal ligament stem cells (hPDLSCs) can differentiate to form bones, cartilage, neurons, adipocytes and blood vessel tissues via *in vitro* induction, and can form a cementum-periodontal ligament-alveolar bone-like structure following *in vivo* implantation ([@b5-ijmm-43-06-2341]-[@b8-ijmm-43-06-2341]). This indicates that hPDLSCs have significant involvement in the reconstruction, regeneration and fixation of periodontal tissue. hPDLSCs were isolated for the first time from the third molar periodontal ligament by Seo *et al* ([@b9-ijmm-43-06-2341]). hPDLSCs are also found on the inner surface of the tooth socket following tooth extraction ([@b10-ijmm-43-06-2341]). Highly purified hPDLSCs clones have also been extracted from periodontal tissues ([@b11-ijmm-43-06-2341]); studies have purified hPDLSCs from inflammatory periodontal ligament tissue and confirmed their potential to regenerate cementum and periodontal ligament ([@b12-ijmm-43-06-2341]). Studies have revealed novel ways of obtaining purified hPDLSCs from suppressed periodontal ligaments ([@b13-ijmm-43-06-2341]-[@b16-ijmm-43-06-2341]). Furthermore, studies have shown that the periodontal inflammatory microenvironment can destroy periodontal tissue by suppressing the regeneration ability of hPDLSCs; however, the underlying mechanism remains to be elucidated ([@b17-ijmm-43-06-2341]).

Due to their proliferation and pluripotent differentiation ability, and their capacity to form Sharpey\'s fibres and cementum-like structures, hPDLSCs are considered the optimal seeding cells in periodontal engineering ([@b18-ijmm-43-06-2341]). The co-implantation of hPDLSCs with hydroxyapatite or β-tricalcium phosphate scaffold in nude mice allowed the formation of periodontal ligament- and cementum-like structures ([@b9-ijmm-43-06-2341]). In addition, animal experiments have revealed that multiple PDLSCs from different sources, including human, canine and swine sources, can initiate the homing effects and facilitate the regeneration of periodontal tissue following implantation ([@b19-ijmm-43-06-2341]-[@b21-ijmm-43-06-2341]). Dentin non-collagen proteins can increase the proliferation and adhesion abilities, facilitate morphological changes, increase alkaline phosphatase (ALP) activity and induce the differentiation of hPDLSCs into cementoblasts ([@b22-ijmm-43-06-2341]). As hPDLSCs cannot express human leukocyte antigen II or co-stimulatory molecules, it is hypothesized that the underlying mechanism of hPDLSC immunosuppression may be achieved by prostaglandin 2-mediated T cell non-responsiveness ([@b23-ijmm-43-06-2341]). Therefore, studies investigating periodontal disease should focus on investigating the molecular mechanisms involved in the osteogenic differentiation of hPDLSCs in the chronic inflammatory microenvironment, in order to provide a theoretical basis for optimizing the stem cell-mediated treatment of periodontal inflammatory diseases.

Toll-like receptors (TLRs) are a class of transmembrane receptors, which can recognize and bind the corresponding pathogen-associated molecular patterns, activate the signal transduction pathway and induce the expression of certain immune effector molecules, including inflammatory cytokines ([@b24-ijmm-43-06-2341]). TLRs are type I transmembrane proteins and can be divided into three structural parts: Extracellular, cytoplasmic and transmembrane. The extracellular domain of TLRs are responsible for receptor recognition and the binding to other auxiliary receptors to form a receptor complex ([@b25-ijmm-43-06-2341],[@b26-ijmm-43-06-2341]). TLR4, the first identified mammalian TLR, is expressed in all cell lines. Findings indicate that TLR4 is important in pro-inflammatory reactions, promoting the maturation and differentiation of immune cells, and regulating immune responses ([@b27-ijmm-43-06-2341]). TLR4 is involved in the inflammatory response to ischemia-reperfusion injury *in vivo*. TLR4 is also involved in the apoptosis of various cell types, including immune cells, hepatocytes, cardiomyocytes, gastric cancer cells, breast cells, renal tubular epithelial cells and airway smooth muscle cells ([@b28-ijmm-43-06-2341]). Studies have demonstrated that mice with deficient TLR4 function exhibit significantly lower ischemia damage compared with wild-type mice. The inhibition of TLR4 can reduce ischemia-reperfusion injury by regulating apoptosis ([@b29-ijmm-43-06-2341]). As a member of the TLR family, TLR4 is a receptor of lipopolysaccharide (LPS) and lipid A in Gram-negative bacteria. When LPS is bound together with TLR4, a cascade of signaling pathways is triggered which can activate the expression of type I interferons (IFN-α and IFN-β), pro-inflammatory cytokines, including interleukin (IL)-1, IL-6 and tumor necrosis factor (TNF)-α, and chemotactic cytokine IL-8 ([@b30-ijmm-43-06-2341]). Previous studies have indicated that the LPS-induced activation of hPDLSCs is followed by activation of the TLR4/MyD88 complex, which causes the release of cytokines, including IL-1α, IL-8 and TNF-α ([@b31-ijmm-43-06-2341]). However, the exact role of TLR4 in the differentiation of hPDLSCs, particularly under inflammatory conditions, and the underlying molecular mechanisms have not been investigated in detail.

The present study aimed to investigate the regulatory roles of TLR4 in the osteogenic and adipogenic differentiation of hPDLSCs under inflammatory conditions, in order to reveal the regulatory role of the TLR4 signaling pathway in stem cell osteogenic differentiation. This may lay a foundation for the diagnosis and treatment of the chronic inflammatory processes and tissue engineering.

Materials and methods
=====================

Isolation and primary culture of hPDLSCs
----------------------------------------

Specimens were collected from patients who underwent orthodontic teeth extraction in the Department of Oral and Maxillofacial Surgery of Hospital of Stomatology, Tongji University. The specimens were divided into two groups of 10 samples: The control group comprised patients without decayed teeth, apical periodontitis or periodontitis, and the experimental group comprised patients with periodontal inflammation. Briefly, following orthodontic extraction, the teeth were transferred into the culture medium and the tooth roots were repeatedly washed with antibiotic-containing PBS to remove the clotted blood. Subsequently, two-thirds of the periodontal membranes in the roots were scraped, and transferred into centrifuge tubes following thorough cutting with scissors. To each tube, 3 ml of 0.1% collagenase was added, and the tube was shaken and digested at 37°C for 50-60 min. Subsequently, 1% trypsin was added for further digestion for 25 min. Thereafter, a small volume of 10% FBS was added to terminate the digestion. Following centrifugation at 700 × g for 10 min at room temperature, the supernatant was discarded and then inoculated into a culture flask. An appropriate quantity of α-MEM culture medium supplemented with 10% FBS (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) was added and placed in an incubator containing 5% CO~2~ at 37°C in saturated humidity. The medium was replaced every 2-3 days and the cells were sub-cultured when they grew to confluence. Finally, the original medium was discarded and the cells were washed with PBS; the cells were then examined under an inverted microscope. In order to examine changes between the normal and malignant/differentiation conditions, only hPDLSCs from healthy subjects were used in the subsequent experiments.

Purification of periodontal membrane stem cells by flow cytometry
-----------------------------------------------------------------

Third passage hPDLSCs were collected, washed with PBS and digested with trypsin. A cell suspension was prepared at a density of 1×10^6^ cells/ml and dispensed into a sterilized EP tube (1.5 ml). The fluorescently marked anti-human Stro-1-APC (cat. no. MA5-28635), CD146-FITC (cat. no. 11-1469-42), CD90-APC (cat. no. 17-0909-42), CD105-PE (cat. no. 12-1051-82), CD29-FITC (cat. no. 11-0291-82), CD31-APC (cat. no. 17-0311-82) and CD45-PE (cat. no. 12-0459-41) antibodies (1:10; all from Thermo Fisher Scientific, Inc.) were added to each tube, separately. The cells were incubated on ice for 1.5 h and subsequently centrifuged at 700 × g for 3 min at room temperature. Finally, the supernatant was discarded and the cells were washed with PBS three times, re-suspended in 3% FBS and subjected to flow cytometric analysis.

Immunohistochemistry and immunofluorescence of hPDLSCs
------------------------------------------------------

The well-grown cells were collected to prepare slides and fixed in 4% paraformaldehyde for 30 min, and TLR4 and Stro-1 were stained for using the immunochemical SABC method. Briefly, following washing three times with PBS (2 min each time), the cells were incubated with 3% Triton-100 solution for 15 min to increase cell permeability. Subsequently, 3% hydrogen peroxide-methanol solution was added for 15 min to eliminate the effect of endogenous peroxidase. The cells were then washed three times with PBS, and normal goat serum (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) blocking solution was added for 15 min to eliminate non-specific staining. Following this, primary antibodies against TLR4 (polyclonal antibody; cat. no. sc-293072; 1:300; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), keratin (polyclonal antibody; cat. no. PA5-68042; 1:300; Thermo Fisher Scientific, Inc.); Stro-1 (rabbit anti-human antibody; cat. no. sc-47733; 1:100; Santa Cruz Biotechnology, Inc.) were added. For the negative control, PBS was used instead of primary antibody and transferred to a refrigerator at 4°C overnight. Following rewarming in a 37°C incubator for 1 h and washing with PBS (5 min, three times), biotinylated secondary antibody (cat. no. ab6788; 1:1,000; Abcam, Cambridge, UK) was added at 37°C for 1 h. Following this, a 1:50 dilution of FITC-labeled goat anti-rabbit IgG (cat. no. sc-2040; 1:50; Santa Cruz Biotechnology, Inc.) was added in the Stro-1 immunofluorescence group. Following washing with PBS and rinsing with distilled water, 500 ml of non-fluorescent buffer glycerol was used for sealing in the Stro-1 immunofluorescence group, whereas SABC reagent was added to the other two groups, and incubated in a 37°C incubator for 20 min. Following DAB staining and hematoxylin staining, examination was performed under an optical microscope.

MTT assay
---------

The fourth passage isolated hPDLSCs were sub-cultured in 96-well plates at a density of 2×10^3^ cells/ml per well (six replicates) in an incubator containing 5% CO~2~ at 37°C. Therefore, 20 *µ*l of 0.5% MTT solution was added every day at a fixed time point, followed by incubation for 4 h. This step was repeated for 14 days. In each case, when culture was stopped, the medium was carefully removed and 150 *µ*l of DMSO was added into each well. The cultures were then shaken at a low speed for 10 min to completely dissolve the crystals. Finally, the absorbance was measured at 490 nm using a spectrophotometric approach.

Cell cycle analysis
-------------------

Cells were collected in the logarithmic growth phase, counted with a hemocytometer and inoculated into 6-well plates at a density of 5×10^5^ cells/ml. From this, \~1×10^6^ cells were collected and transferred into a centrifuge tube. Following centrifugation at 700 × g for 5 min at room temperature, the supernatant was discarded and the cells were washed with PBS and resuspended with 0.5 ml PBS in the tube. Subsequently, 75% cold ethanol was added and mixed, followed by storage at −20°C for 24 h. During the assay, the ethanol was discarded by centrifugation, washed with PBS and resuspended with 1 ml PBS. RNase (5 *µ*l, 10 mg/ml) was added and followed by incubation in a water bath at 37°C for 1 h. Propidium iodide (PI; 5 *µ*l, 10 mg/ml) was then added, followed by incubation at room temperature for 30 min in the dark. Finally, the cell cycle was detected by flow cytometry.

Pluripotency induction
----------------------

Cells at logarithmic growth phase were cultured at a density of 2×10^4^ cells/ml in a six-well plate with coverslips in an incubator at 37°C containing 5% CO~2~. The medium was replaced every 3 days, and when the cells reached 60% confluence, the culture medium was replaced with osteogenic, chondrogenic and adipogenic culture medium. The conventional standard medium was used as a control. The cells were collected on the 14th day and the medium was discarded. Fixation was performed using 4% formaldehyde (for Alizarin Red S staining) or formalin (Oil Red O staining) for 15 min at room temperature followed by washing (twice) with PBS. The cells were finally stained with Alizarin Red S and Oil Red O, respectively, and were visualized and analyzed under a microscope.

ALP assays
----------

ALP activity was assessed using an ALP assay kit. The cells were washed and, following measurement of the cell concentration, 50 *µ*l of the assay buffer was added and followed by centrifugation at 11,900 × g for 3 min at 4°C. Following this, 50 *µ*l of 5 mM PNPP reaction solution was added to each well and reacted at 60°C for 60 min in the dark. Finally, 20 *µ*l of the stop solution was added and mixed, and the values of absorbance were measured at 405 nm. Each assay condition was performed in triplicate and the results were repeated in at least three independent experiments. ALP activity was normalized by total cellular protein concentrations among the samples.

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis
-------------------------------------------------------------------------------

Total RNA was extracted from the hPDLSCs of the normal and inflammation groups using TRIzol reagent and reverse transcribed into cDNA. PCR primers ([Table I](#tI-ijmm-43-06-2341){ref-type="table"}) were designed using the Primer3 program (<http://bioinfo.ut.ee/primer3-0.4.0/>). SYBR-Green-based qPCR analysis was performed to amplify the genes of interest using the RG-3000 Real-Time DNA Detection system (Corbett Research; Qiagen, Inc., Valencia, CA, USA). Triplicate reactions were performed for each sample. The amplification system was as follows: Power SYBR^®^-Green Master Mix 10 *µ*l, Forward Primer (10 *µ*M) 0.5 *µ*l, Reverse Primer (10 *µ*M) 0.5 *µ*l, cDNA 1 *µ*l, ddH~2~O up to 20 *µ*l. The amplification conditions were as follows: 94°C for 2 min for one cycle and 30 cycles at 92°C for 20 sec, 57°C for 30 sec, and 72°C for 20 sec, followed by extension at 78°C for each cycle. The relative expression levels of OCN, RUNX2, LPL, COLI, TLR4, NF-κBP65, ALP, PPARγ were calculated using the 2^−ΔΔCq^ method ([@b32-ijmm-43-06-2341]). All samples were run in triplicate and normalized by the endogenous expression level of GAPDH.

Stimulation and culture of hPDLCs
---------------------------------

The cells were divided into a control group, TLR4 activation group (LPS-PG, 10 ng/ml, 24 h), TLR4 antagonist group (TLR4 antagonist, 1 *µ*g/ml, 24 h), osteogenic induction control group, osteo-genic induction and agonist group, and osteogenic induction and antagonist group. Each group of cells were cultured in α-MEM medium (D-glucose 1,000 mg/l, L-glutamine 292 mg/l, sodium pyruvate 110 mg/l, NaHCO~3~ 2200 mg/l, Penicillin 100 U/ml, Streptomycin 100 *µ*g/ml, pH 7.0-7.4) supplemented with 10% FBS (Gibco; Thermo Fisher Scientific, Inc.), and placed in an incubator containing 5% CO~2~ at 37°C in a saturated humidity.

Scratch assay
-------------

The back of a 6-well plate was marked with uniformly horizontal lines, separated by 0.5-1 cm. Each well included at least five lines. The cells (\~5×10^5^) were added to each well and incubated overnight. The following day, a pipette tip and ruler were used to scratch perpendicularly to the back horizontal line. The cells were washed three times with PBS, added to serum-free cell culture medium and incubated for 24 h in a 37°C incubator containing 5% CO~2~. Images were captured by using an inverted phase microscope (Nikon Corporation, Tokyo, Japan) at 0, 24 and 48 h.

Enzyme-linked immunosorbent assay (ELISA)
-----------------------------------------

Briefly, 96-well polysorp plates (Nalge Nunc International, Penfield, NY, USA) were coated with recombinant tubulin-α-1c protein at a concentration of 10 *µ*g/ml in 0.05 M carbonate buffer at 4°C overnight. The wells were then washed with PBS containing 0.05% Tween-20 (PBS-T) four times and blocked with 3% BSA-PBS for 3.5 h at 37°C. The samples were diluted at 1:100 with PBS-T containing 1% BSA and were added to the 96-well plate. Wells filled with PBS-T containing 1% BSA without samples were set up to examine non-specific background. Following incubation for 1.5 h at 37°C, the wells were washed six times with PBS-T. Subsequently, 100 *µ*l of goat anti-human IgG conjugated to peroxidase, (cat. no. 109-001-003; 1:5,000; Jackson Immunoresearch Laboratories, West Grove, PA, USA), was added to each well and incubated for 30 min at 37°C. Following washing with PBS-T four times, the bound antibodies were detected with o-phenylenediamine as substrate. The reaction was terminated by adding 100 *µ*l of 2 M sulfuric acid to each well. The values of absorbance were measured at 450 nm using a Bio-Rad plate reader.

Apoptosis detection
-------------------

The cells were collected and re-suspended in PBS. The cells (1×10^4^) were centrifuged at 700 × g for 5 min at room temperature and the supernatant discarded. The cells were gently re-suspended by adding 500 *µ*l of Annexin V-FITC conjugate. The cells were then mixed and incubated at room temperature for 10 min in the dark. Following centrifugation at 700 × g for 5 min at room temperature, the supernatant was discarded and the cells were gently re-suspended by adding 500 *µ*l of Annexin V-FITC Binding Solution. Following this, 10 *µ*l of PI staining solution was added, followed by gentle mixing in an ice bath in the dark. Flow cytometry was then used for the detection of apoptosis.

Western blot analysis
---------------------

Briefly, the cells were collected and lysed in RIPA buffer. The BCA method was used to detect protein concentration, and 30 *µ*g of protein was loaded onto a 10% gradient SDS-PAGE gel. Following electrophoretic separation, the proteins were transferred onto an Immobilon-P membrane. The membranes were blocked with Super-Block Blocking Buffer, and probed with primary antibodies targeting NF-κBP65 (cat. no. sc-156137), TLR4 (cat. no. sc-293072), and GAPDH (cat. no. sc-47724; all 1:1,000; all from Santa Cruz Biotechnology, Inc.) followed by incubation with a secondary antibody conjugated to horseradish peroxidase (cat. no. sc-2354; 1:5,000; Santa Cruz Biotechnology, Inc.). The proteins were detected using the SuperSignal West Pico Chemiluminescent Substrate kit (Thermo Fisher Scientific, Inc.) and quantified using ImageJ Software (version 1.48; National Institutes of Health, Bethesda, MD, USA).

Statistical analysis
--------------------

GraphPad Prism software version 6 (GraphPad Software, Inc., La Jolla, CA, USA) for Windows was used to complete the statistical analysis. The data are expressed as the mean ± standard deviation. One-way analysis of variance was performed and followed by Tukey\'s multiple comparison post hoc test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

Isolation of hPDLSCs
--------------------

As shown in [Fig. 1A-D](#f1-ijmm-43-06-2341){ref-type="fig"}, from the 5th day of culture adhesion, cells emerged from the edge of the tissue block, most of which showed structures including long spindle-shaped or irregular polygons. Cells in the center of the tissue block were condensed, whereas peripheral cells were radial in growth. The cell body was full and the nucleus clear. With subculture, cell density was increased. The proliferation rates of the passage 1 and passage 2 cells were accelerated. Following inoculation at the ratio of 1:3, the appearance of the cells was monolayer cell fusion, and the cells were long spindle-shaped and arranged in bundles. The flow cytometry results ([Fig. 2](#f2-ijmm-43-06-2341){ref-type="fig"}) showed that the expression levels of CD31, CD45, CD146, CD90, CD105, CD29 and Stro-1 in the negative control group were all \<1%, and the indices of the hPDLSCs in the inflammatory groups (CD146, CD90, CD105, CD29 and Stro-1) were all positive, indicating that isolation of the hPDLSCs had been successful.

LPS induces the inflammation of hPDLSCs and increases the expression of TLR4
----------------------------------------------------------------------------

The expression levels of Stro-1 and keratin were detected by immunofluorescence. As shown in [Fig. 3A and B](#f3-ijmm-43-06-2341){ref-type="fig"}, Stro-1 was positively expressed in the control and inflammation groups, whereas keratin was not expressed. The expression of Stro-1 in the control group was increased compared with that in the inflammation group, indicating that inflammation affected cell growth. In addition, the immunohistochemistry analysis showed that the expression of TLR4 was increased in the inflammation group ([Fig. 3C](#f3-ijmm-43-06-2341){ref-type="fig"}). The MTT assay showed that the logarithmic cell growth phase was obtained between 3 and 8 days, whereas the stable growth phase was reached in 8-10 days ([Fig. 4A](#f4-ijmm-43-06-2341){ref-type="fig"}). The absorbance in the inflammation group was lower than that in the control group, indicating that inflammation affected the cell proliferation rate. Flow cytometric analysis of the cell cycle ([Fig. 4B and C](#f4-ijmm-43-06-2341){ref-type="fig"}) showed that the frequency of hPDLSCs in the G1 phase in the control group was higher than that in the inflammation group. By contrast, the frequency of hPDLSCs in the G2 phase was lower compared with that in the inflammation group, indicating that inflammation affected the cell cycle. The Alizarin Red staining showed that hPDLSCs in the control and inflammation groups were positively stained and the number of calcium nodules in the control group was higher compared with that in the inflammation group ([Fig. 4D](#f4-ijmm-43-06-2341){ref-type="fig"}), suggesting that inflammation inhibited osteogenic differentiation. The number of oil droplets in the control group was lower than that in the inflammation group ([Fig. 4D](#f4-ijmm-43-06-2341){ref-type="fig"}), suggesting that there was induction of adipo-differentiation by LPS. The activity of ALP in the hPDLSCs in the control group was higher than that in the inflammation group, indicating decreased osteogenic differentiation in the inflammation group (P\<0.05; [Fig. 4E](#f4-ijmm-43-06-2341){ref-type="fig"}). The RT-qPCR results indicated that the expression levels of OCN, Runx2 and COL1 in the control group were higher than those in the inflammatory group, and the expression levels of the adipogenesis-related genes, including poly (ADP-ribose) polymerase (PPAR)γ and lipoprotein lipase (LPL), were lower than those in the inflammatory group, indicating that the cells in the control group had higher osteogenic capacity than those in the inflammatory group, whereas lipogenic capacity was lower in the control group than in the inflammation group (P\<0.05; [Fig. 4F](#f4-ijmm-43-06-2341){ref-type="fig"}).

Long-term TLR4 activation inhibits cell proliferation and migration but increases inflammation and apoptosis of hPDLSCs
-----------------------------------------------------------------------------------------------------------------------

The results of the MTT assay ([Fig. 5A](#f5-ijmm-43-06-2341){ref-type="fig"}) showed that cell proliferation in the control group increased with time. Cell proliferation in the TLR4 activation group was increased between 0 and 48 h but decreased at 72 h, indicating that TLR4 activation stimulated cell proliferation within a certain period of time, following which the proliferation ability was reduced. The scratch assay ([Fig. 5B](#f5-ijmm-43-06-2341){ref-type="fig"}) showed that a large number of cells migrated into the scratch area in the control group, whereas fewer cells had migrated in the TLR4 activation group. In addition, in the TLR4 antagonist group, an increased number of cells was observed in the scratch area, but this was relatively lower than the control group. The ELISA assay indicated that the concentrations of IL-1β and TNF-α in the TLR4 activation group were higher compared with those in the other groups (P\<0.05; [Fig. 5C](#f5-ijmm-43-06-2341){ref-type="fig"}). The levels of IL-1β and TNF-α in the control group were lower compared with those in the other groups. In the TLR4 antagonist group, the levels of IL-1β and TNF-α were higher than in the control group but lower that in the TLR4 activation group ([Fig. 5C](#f5-ijmm-43-06-2341){ref-type="fig"}). The flow cytometric assay of apoptosis indicated that the apoptotic rate of cells in the TLR4 activation group was higher compared with the rates in the other groups (P\<0.05), but the rate in the TLR4 antagonist group was higher compared with that in the control group ([Fig. 5D](#f5-ijmm-43-06-2341){ref-type="fig"}). Therefore, TLR4 activation inhibits the proliferation and migration, but induces the inflammation and apoptosis of hPDLSCs.

NF-κBP65/TLR4 axis is involved in the osteogenic differentiation of hPDLSCs
---------------------------------------------------------------------------

In order to investigate the involvement of the NF-κBP65/TLR4 axis, western blotting was used to detect the expression of NF-κBp65 and TLR4 in the different groups. The expression levels of NF-κBp65 and TLR4 were increased in the TLR4 activation group compared with those in the other groups (P\<0.05; [Fig. 6A and B](#f6-ijmm-43-06-2341){ref-type="fig"}). The expression of NF-κBp65 in the control group was significantly lower compared with that in the other groups. No significant difference in the expression of TLR4 was found between the TLR4 antagonist group and the control group. The number of Alizarin Red S-stained mineralized nodules in the LPS-induced cells cultured in normal medium in presence of TLR4 antagonist and in the control group was higher compared with that in the TLR4 agonist group ([Fig. 6C](#f6-ijmm-43-06-2341){ref-type="fig"}). The same trend was observed in the osteogenic medium, in which the number of mineralized nodules was higher compared with that in the normal medium ([Fig. 6C](#f6-ijmm-43-06-2341){ref-type="fig"}). The results of the RT-qPCR analysis confirmed that the expression of NF-κBp65 in the TLR4 activation group was higher compared with that in the other groups (P\<0.05) and the lowest expression levels were found in the control group. Compared with the control group, the expression levels of osteogenic genes (OCN, Runx2 and COL1) and ALP were decreased by treatment of the LPS-induced cells with TLR4 agonist, whereas the TLR4 antagonist reversed this effect. The inverse results were observed for the adipogenic genes (PPARγ and LPL). Similar trends in the expression levels of these genes were recorded in the osteogenic induction medium (P\<0.05; [Fig. 7](#f7-ijmm-43-06-2341){ref-type="fig"}). These results indicated that the NF-κBp65/TLR4 axis is involved and may inhibit the osteogenic differentiation of hPDLSCs under inflammatory conditions.

Discussion
==========

TLR4 is a known natural receptor for LPS, which is significantly increased in tissues with severe periodontitis, suggesting that TLR4 may be involved in periodontal tissue immune processes ([@b33-ijmm-43-06-2341],[@b34-ijmm-43-06-2341]). However, the regulatory role of the TLR4 signaling pathway in hPDLSCs under inflammatory conditions has not been elucidated. The present study aimed to investigate the functional role of TLR4 signaling in hPDLSCs induced with LPS. It was found that LPS induced inflammation of the hPDLSCs and increased the expression of TLR4 in the cell. Additionally, the TLR4 agonist decreased the levels of inflammatory markers in hPDLSCs and inhibited the osteogenic differentiation of these cells. Of note, the study revealed the NF-κBP65/TLR4 axis is a key regulatory pathway driving the osteogenic differentiation of hPDLSCs.

TNF-α and IL-1β are inflammatory factors produced downstream of TLR4. When TLR4 is specifically activated by LPS on hPDLSCs, its downstream signaling pathway is activated and expresses various inflammatory factors, including TNF-α and IL-1β. Wang *et al* found a positive correlation between the expression of TLR4 and TNF-α on the surface of gingival fibroblasts ([@b35-ijmm-43-06-2341]). Additionally, they found that LPS of *Porphyromonas gingivalis* can be combined with TLR4 on the gingival fibroblast membrane to transmit intracellularly, stimulating gingival fibroblasts to produce inflammatory cytokines IL-1 and IL-6, which can activate osteoclasts and cause alveolar bone resorption. Sun *et al* found that the expression levels of TLR4 and IL-6 were significantly increased in hPDLSCs cultured *in vitro* following LPS stimulation ([@b36-ijmm-43-06-2341]). Similarly, Scheres *et al* found high mRNA expression levels of TLR4, TLR7 and CD14 in periodontitis on culturing periodontal cells in healthy and periodontitis groups ([@b37-ijmm-43-06-2341]). Chaudhari *et al* detected that the IL-1β content in the gingival tissues of patients with periodontitis was more than twice that of normal individuals, confirming that IL-1β is involved in the immune response, inflammation and alveolar bone resorption of periodontal tissues ([@b38-ijmm-43-06-2341]). The present study found that inflammation induced by LPS inhibited the osteogenic differentiation, proliferation and migration of hPDLSCs. In addition, it was found that only low levels of TNF-α and IL-1β were expressed in hPDLSCs under normal conditions. Following LPS stimulation, the expression levels of TNF-α, IL-1β and NF-κBp65 increased with the increased expression of TLR4, indicating that LPS stimulated the hPDLSCs, and increased the expression of TLR4 and the release of inflammatory factors. These LPS-induced changes caused inflammatory damage, subsequently leading to periodontitis.

A limitation of the present study was that it did not examine whether treatment with the TLR4 antagonist prevented or reversed the harmful response induced by LPS or the agonist.

In conclusion, LPS-induced upregulation of the TLR4 signaling pathway induced the expression of proinflammatory cytokines IL-1β, TNF-α, NF-κBP65, and inhibited osteogenic differentiation, but induced adipogenesis of the hPDLSCs. The NF-κBP65/TLR4 axis is a key regulatory pathway driving the osteogenic differentiation of hPDLSCs under inflammatory conditions, which can provide novel targets for controlling periodontal inflammation and immune response, and potentially novel methods for the clinical prevention and treatment of periodontal disease.
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![Isolation and culture of hPDLSCs from tissue blocks. Tissue blocks were cultured for (A) 5 days and (B) 7 days. Primary hPDLSCs sub-cultured for (C) P1 and (D) P2. hPDLSCs, human periodontal ligament stem cells; D, day; P, passage.](IJMM-43-06-2341-g00){#f1-ijmm-43-06-2341}

![Identification and purification of hPDLSCs by flow cytometry. hPDLSCs, human periodontal ligament stem cells.](IJMM-43-06-2341-g01){#f2-ijmm-43-06-2341}

![Immunofluorescence and immunohistochemistry of human periodontal ligament stem cells. (A) Positive staining of Stro-1. (B) Negative staining of keratin. (C) Positive staining of TLR4. TLR4, Toll-like receptor 4.](IJMM-43-06-2341-g02){#f3-ijmm-43-06-2341}

![Effect of inflammation on human periodontal ligament stem cells. (A) Cell proliferation detected using an MTT assay; (B) cell cycle analysis; (C) distribution of cell cycle detected by flow cytometry; (D) pluripotency induction (osteogenic differentiation and adipogenic differentiation); (E) relative content of ALP; (F) relative content of osteogenic induction genes (OCN, Runx2 and COL1) and adipogenesis-related genes (PPARγ and LPL). ^\*^P\<0.05, vs. Control group. LPS, lipopolysaccharide; ALP, alkaline phosphatase; OCN, osteocalcin; Runx2, Runt-related transcription factor 2; Col1, collagen I; PPAR, poly (ADP-ribose) polymerase; LPL, lipoprotein lipase; D, day.](IJMM-43-06-2341-g03){#f4-ijmm-43-06-2341}

![Functions of the TLR4 agonist and antagonist on hPDLSCs. Effects of the TLR4 agonist and antagonist on (A) cell proliferation and (B) cell migration. (C) Expression levels of IL-1β and TNF-α. (D) Apoptosis of hPDLSCs detected by flow cytometry. ^\*^P\<0.05 vs. Control group; ^\#^P\<0.05 vs. TLR4 Agonist group. hPDLSCs, human periodontal ligament stem cells; LPS, lipopolysaccharide; TLR4, Toll-like receptor 4.](IJMM-43-06-2341-g04){#f5-ijmm-43-06-2341}

![Effects of the TLR4 agonist and antagonist on the osteogenic differentiation of human periodontal ligament stem cells. (A) Expression of NF-κBp65 and TLR4 (1, Control; 2, TLR4 agonist; 3, TLR4 antagonist). (B) Quantification of levels of NF-κBp65 and TLR4. (C) Osteogenic differentiation ability was detected by staining with Alizarin Red. ^\*^P\<0.05 vs. Control group; ^\#^P\<0.05 vs. TLR4 agonist group. NF-κBp65, nuclear factor-κBp65; TLR4, Toll-like receptor 4; LPS, lipopolysaccharide.](IJMM-43-06-2341-g05){#f6-ijmm-43-06-2341}

![Expression levels of osteogenic induction genes (OCN, Runx2 and COL1), adipogenesis-related genes (PPARγ and LPL), ALP, NF-κBp65 and TLR4. ^\*^P\<0.05 vs. C group; ^\#^P\<0.05 vs. TA group. TLR4, Toll-like receptor 4; C, Control; TA, TLR4 agonist; Tan, TLR4 antagonist; OIC, osteogenic induction control; OITA, osteogenic induction TLR4 agonist; OITAn, osteogenic induction TLR4 antagonist; ALP, alkaline phosphatase; OCN, osteocalcin; Runx2, Runt-related transcription factor 2; Col1, collagen I; PPAR, poly (ADP-ribose) polymerase; LPL, lipoprotein lipase.](IJMM-43-06-2341-g06){#f7-ijmm-43-06-2341}

###### 

Primer sequences.

  Primer       Sequence (5′-3′)        Temperature (°C)   Gene size (bp)
  ------------ ----------------------- ------------------ ----------------
  GAPDH-F CC   TGCACCACCAACTGCTTA      60.54              144
  GAPDH-R C    ATCACGCCACAGCTTTCCA     61.24              
  OCN-F        ATTGTGACGAGCTAGCGGAC    60.18              131
  OCN-R        TCGAGTCCTGGAGAGTAGCC    60.11              
  RUNX2-F      TGGCCGGGAATGATGAGAAC    60.11              79
  RUNX2-R      TTGAACCTGGCCACTTGGTT    60.03              
  LPL-F        CATGCAAGAACGGTGCCAAG    59.96              169
  LPL-R C      TCACAGTGATGGCCTGTGT     59.96              
  COLI-F       TGCGACAGTCTGGATGTCTT    59.03              184
  COLI-R       TGAAGGACCCGGATTTCACG    60.04              
  TLR4-F       TGTATCGGTGGTCAGTGTGC    60.04              172
  TLR4-R       CAGCTCGTTTCTCACCCAGT    59.97              
  NF-κBP65-F   GATCCTTTCGGAACTGGGCA    60.04              113
  NF-κBP65-R   AGGTATGGGCCATCTGTTGAC   59.79              
  ALP-F        GCAGCACTCCTTCCGGTATT    60.11              156
  ALP F-R      GTACAATCTTCACGCCCGGA    60.11              
  PPARr-F      ATTCGGCTAAAGCTGGCGTA    59.82              106
  PPARγ-R      TGCATTGTGTGACATCCCGA    59.96              

F, forward; R, reverse; OCN, osteocalcin; RUNX2, Runt-related transcription factor 2; LPL, lipoprotein lipase; COLI, collagen I; TLR4, Toll-like receptor 4; NF-κBp65, nuclear factor-κBp65; ALP, alkaline phosphatase; PPAR, poly (ADP-ribose) polymerase.

[^1]: Contributed equally
